COMPARISON OF THE EFFECTS OF AMLODIPINE AND LOSARTAN ON 24-HOUR AMBULATORY BLOOD PRESSURE IN HYPERTENSIVE PATIENTS

REFERENCES

• The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch. Intern. Med. 1997; 157: 2413–2446
   PubMed Web of Science ®Google Scholar
• Chalmers J., Zanchetti A. The 1996 Report of a World Health Organization Expert Committee on Hypertension Control. J. Hypertens. 1996; 14: 929–933
   PubMed Web of Science ®Google Scholar
• Siegel D., Lopez J. Trends in Antihypertensive Drug Use in the United States. JAMA 1997; 278: 1745–1748
   PubMed Web of Science ®Google Scholar
• Staessen J. A., Fagard R., Thijs L., Celis H., Arabidze G. G., Birkenhager W. H., Bulpitt C. J., de Leeuw P. W., Dollery C. T., Fletcher A. E., Forette F., Leonetti G., Nachev C., O'Brien E. T., Rosenfeld J., Rodicio J. L., Tuomilehto J., Zanchetti A. Randomised Double-blind Comparison of Placebo and Active Treatment for Older Patients with Isolated Systolic Hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial. Lancet 1997; 350: 757–764
   PubMed Web of Science ®Google Scholar
• Hansson L., Zanchetti A., Carruthers S. G., Dahlof B., Elmfeldt D., Julius S., Menard J., Rahn K. H., Wedel H., Westerling S. Effects of Intensive Blood-pressure Lowering and Low-dose Aspirin in Patients with Hypertension: Principal Results of the Hypertension Optimal Treatment (HOT) Randomised Trial. HOT Study Group [see comments]. Lancet 1998; 351: 1755–1762
   PubMed Web of Science ®Google Scholar
• Hansson L., Lindholm L. H., Ekbom T., Dahlof B., Lanke J., Schersten B., Wester P. O., Hedner T., de Faire U. Randomised Trial of Old and New Antihypertensive Drugs in Elderly Patients: Cardiovascular Mortality and Morbidity the Swedish Trial in Old Patients with Hypertension-2. Lancet 1999; 354: 1751–1756
   PubMed Web of Science ®Google Scholar
• Psaty B. M., Heckbert S. R., Koepsell T. D., Siscovick D. S., Raghunathan T. E., Weiss N. S., Rosendaal F. R., Lemaitre R. N., Smith N. L., Wahl P. W., Wagner E. H., Furberg. The Risk of Myocardial Infarction Associated with Antihypertensive Drug Therapies. JAMA 1995; 274: 620–625
   PubMed Web of Science ®Google Scholar
• Ishikawa K., Nakai S., Takenaka T., Kanamasa K., Hama J., Ogawa I., Yamamoto T., Oyaizu M., Kimura A., Yamamoto K., Yabushita H., Katori R. Short-acting Nifedipine and Diltiazem Do Not Reduce the Incidence of Cardiac Events in Patients with Healed Myocardial Infarction. Secondary Prevention Group. Circulation 1997; 95: 2368–2373
   PubMed Web of Science ®Google Scholar
• Packer M., O'Connor C. M., Ghali J. K., Pressler M. L., Carson P. E., Belkin R. N., Miller A. B., Neuberg G. W., Frid D., Wertheimer J. H., Cropp A. B., DeMets D. L. Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure. Prospective Randomized Amlodipine Survival Evaluation Study. N. Engl. J. Med. 1996; 335: 1107–1114
   PubMed Web of Science ®Google Scholar
• Pitt B., Poole-Wilson P. A., Segal R., Martinez F. A., Dickstein K., Camm A. J., Konstam M. A., Riegger G., Klinger G. H., Neaton J., Sharma D., Thiyagarajan B. Effect of Losartan Compared with Captopril on Mortality in Patients with Symptomatic Heart Failure: Randomised Trial—the Losartan Heart Failure Survival Study ELITE II. Lancet 2000; 355: 1582–1587
   PubMed Web of Science ®Google Scholar
• Morgan T., Menard J., Brunner H. Trough to Peak Ratio as a Guide to BP Control: Measurement and Calculation. J. Hum. Hypertens. 1998; 12: 49–53
   PubMed Web of Science ®Google Scholar
• Yoshiike N., Matsumura Y., Zaman M. M., Yamaguchi M. Descriptive Epidemiology of Body Mass Index in Japanese Adults in a Representative Sample from the National Nutrition Survey 1990–1994. Int. J. Obesity 1998; 22: 684–687
   Web of Science ®Google Scholar
• Appel L. J., Stason W. B. Ambulatory Blood Pressure Monitoring and Blood Pressure Self-measurement in the Diagnosis and Management of Hypertension. Ann. Intern. Med. 1993; 118: 867–882
   PubMed Web of Science ®Google Scholar
• Muiesan M. L., Pasini G., Salvetti M., Calebich S., Zulli R., Castellano M., Rizzoni D., Bettoni G., Cinelli A., Porteri E., Corsetti V., Agabiti-Rosei E. Cardiac and Vascular Structural Changes. Prevalence and Relation to Ambulatory Blood Pressure in a Middle-aged General Population in Northern Italy: The Vobarno Study. Hypertension 1996; 27: 1046–1052
   PubMed Web of Science ®Google Scholar
• Palatini P., Penzo M., Racioppa A., Zugno E., Guzzardi G., Anaclerio M., Pessina A. C. Clinical Relevance of Nighttime Blood Pressure and of Daytime Blood Pressure Variability. Arch. Intern. Med. 1992; 152: 1855–1860
   PubMed Web of Science ®Google Scholar
• Hoegholm A., Bang L. E., Kristensen K. S., Nielsen J. W., Holm J. Microalbu- minuria in 411 Untreated Individuals with Established Hypertension, White Coat Hypertension, and Normotension. Hypertension 1994; 24: 101–105
   PubMed Web of Science ®Google Scholar
• Suzuki Y., Kuwajima I., Kanemaru A., Shimosawa T., Hoshino S., Sakai M., Matsushita S., Ueda K., Kuramoto K. The Cardiac Functional Reserve in Elderly Hypertensive Patients with Abnormal Diurnal Change in Blood Pressure. J. Hypertens. 1992; 10: 173–179
   PubMed Web of Science ®Google Scholar
• Frattola A., Parati G., Cuspidi C., Albini F., Mancia G. Prognostic Value of 24-hour Blood Pressure Variability. J. Hypertens. 1993; 11: 1133–1137
   PubMed Web of Science ®Google Scholar
• ISIS-2 Collaborative Group. Morning Peak in the Incidence of Myocardial Infarction: Experience in the ISIS-2 Trial. Eur. Heart. J. 1992; 13: 594–598
   PubMed Web of Science ®Google Scholar
• Willich S. N., Goldberg R. J., Maclure M., Perriello L., Muller J. E. Increased Onset of Sudden Cardiac Death in the First Three Hours after Awakening. Am. J. Cardiol. 1992; 70: 65–68
   PubMed Web of Science ®Google Scholar
• Argentino C., Toni D., Rasura M., Violi F., Sacchetti M. L., Allegretta A., Balsano F., Fieschi C. Circadian Variation in the Frequency of Ischemic Stroke. Stroke 1990; 21: 387–389
   PubMed Web of Science ®Google Scholar
• Kelly-Hayes M., Wolf P. A., Kase C. S., Brand F. N., McGuirk J. M., D'Agostino R. B. Temporal Patterns of Stroke Onset. The Framingham Study. Stroke 1995; 26: 1343–1347
   PubMed Web of Science ®Google Scholar
• Linsell C. R., Lightman S. L., Mullen P. E., Brown M. J., Causon R. C. Circadian Rhythms of Epinephrine and Norepinephrine in Man. J. Clin. Endocrinol. Metab. 1985; 60: 1210–1215
   PubMed Web of Science ®Google Scholar
• Brezinski D. A., Tofler G. H., Muller J. E., Pohjola-Sintonen S., Willich S. N., Schafer A. I., Czeisler C. A., Williams G. H. Morning Increase in Platelet Aggregability. Association with Assumption of the Upright Posture. Circulation 1988; 78: 35–40
   PubMed Web of Science ®Google Scholar
• Darnis F., Poupon R. Pharmacokinetics and Safety of Single Oral Doses of Amlodipine in Patients with and Without Hepatic Impairment: An Open Study. Int. J. Clin. Pharmacol. Res. 1993; 13: 29–33
   PubMedGoogle Scholar
• Lo M. W., Goldberg M. R., McCrea J. B., Lu H., Furtek C. I., Bjornsson T. D. Pharmacokinetics of Losartan, an Angiotensin II Receptor Antagonist, and its Active Metabolite EXP3174 in Humans. Clin. Pharmacol. Ther. 1995; 58: 641–649
   PubMed Web of Science ®Google Scholar
• Messerli F. H. …and Losartan was no Better than Placebo. J. Hum. Hypertens. 1999; 13: 649–650
   PubMed Web of Science ®Google Scholar
• Furberg C. D., Psaty B. M., Meyer J. V. Nifedipine. Dose-related Increase in Mortality in Patients with Coronary Heart Disease. Circulation 1995; 92: 1326–1331
   PubMed Web of Science ®Google Scholar
• The GLANT Study Group. A 12-month Comparison of ACE Inhibitor and CA Antagonist Therapy in Mild to Moderate Essential Hypertension. The GLANT Study. Hypertens. Res. 1995; 18: 235–244
   PubMedGoogle Scholar
• Hamada T., Watanabe M., Kaneda T., Ohtahara A., Kinugawa T., Hisatome I., Fujimoto Y., Yoshida A., Shigemasa C. Evaluation of Changes in Sympathetic Nerve Activity and Heart Rate in Essential Hypertensive Patients Induced by Amlodipine and Nifedipine. J. Hypertens. 1998; 16: 111–118
   PubMed Web of Science ®Google Scholar
• Minami J., Ishimitsu T., Kawano Y., Matsuoka H. Comparison of Autonomic Nerve Activity with Amlodipine and Nifedipine Retard in Hypertensive Patients. Clin. Exp. Pharmacol. Physiol. 1998; 25: 572–576
   PubMed Web of Science ®Google Scholar
• Julius S. Interaction Between Renin and the Autonomic Nervous System in Hypertension. Am. Heart. J. 1988; 116: 611–616
   PubMed Web of Science ®Google Scholar
• Elkayam U., Amin J., Mehra A., Vasquez J., Weber L., Rahimtoola S. H. A Prospective, Randomized, Double-blind, Crossover Study to Compare the Efficacy and Safety of Chronic Nifedipine Therapy with that of Isosorbide Dinitrate and their Combination in the Treatment of Chronic Congestive Heart Failure. Circulation 1990; 82: 1954–1961
   PubMed Web of Science ®Google Scholar
• Goldstein R. E., Boccuzzi S. J., Cruess D., Nattel S. Diltiazem Increases Late-onset Congestive Heart Failure in Postinfarction Patients with Early Reduction in Ejection Fraction. Circulation 1991; 83: 52–60
   PubMed Web of Science ®Google Scholar
• Pitt B., Byington R. P., Furberg C. D., Hunninghake D. B., Macini J., Miller M. E., Riley W. Effect of Amlodipine on the Progression of Atherosclerosis and Occurrence of Clinical Events. Circulation 2000; 102: 1503–1510
   PubMed Web of Science ®Google Scholar
• The CONSENSUS Trial Study Group. Effects of Enalapril on Mortality in Severe Congestive Heart Failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). New. Engl. J. Med. 1987; 316: 1429–1435
   PubMed Web of Science ®Google Scholar
• The SOLVD Investigators. Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure. New. Engl. J. Med. 1991; 325: 293–302
   PubMed Web of Science ®Google Scholar